Issued Patents 2024
Showing 1–5 of 5 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12036279 | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Jedd D. Wolchok, Weiyi Wang, Peihong Dai +1 more | 2024-07-16 |
| 11993653 | Antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Jedd D. Wolchok +8 more | 2024-05-28 |
| 11986503 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Jedd D. Wolchok, Weiyi Wang, Peihong Dai +1 more | 2024-05-21 |
| 11897962 | Anti-GITR antibodies and methods of use thereof | Volker Seibert, Olivier Leger, Marc van Dijk, David Schaer, Gerd Ritter +1 more | 2024-02-13 |
| 11884939 | Vaccinia virus mutants useful for cancer immunotherapy | Liang Deng, Stewart Shuman, Ning-Sun Yang, Jedd D. Wolchok | 2024-01-30 |